- Papers in database
- 6
- Primary author
- 3 papers
- Years active
- 2015 – 2021
- Health outcomes studied
- 2
Health Outcomes Studied
Papers (6)
- 2021Lactobacillus Sps in Reducing the Risk of Diabetes in High-Fat Diet-Induced Diabetic Mice by Modulating the Gut Microbiome and Inhibiting Key Digestive Enzymes Associated with Diabetes10.3390/biology10040348
- 2020Primary authorOral Administration of Live and Dead Cells of Lactobacillus sakei proBio65 Alleviated Atopic Dermatitis in Children and Adolescents: a Randomized, Double-Blind, and Placebo-Controlled Study10.1007/s12602-020-09654-7
- 2019Primary authorEffect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model10.1016/j.sjbs.2019.09.004
- 2018Primary authorProbiotic Lactobacillus sakei proBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model10.3389/fmicb.2018.01021
- 2016Characterization and Antibacterial Potential of Lactic Acid Bacterium Pediococcus pentosaceus 4I1 Isolated from Freshwater Fish Zacco koreanus10.3389/fmicb.2016.02037
- 2015A Double-Blind, Placebo Controlled-Trial of a Probiotic Strain Lactobacillus sakei Probio-65 for the Prevention of Canine Atopic Dermatitis.10.4014/jmb.1506.06065